Featured Content
From chief operating officers to division chiefs, here are 25 cancer center leadership moves Becker’s has covered in 2026:
Most Read
The Latest
NYC Health + Hospitals/South Brooklyn Health has opened a newly renovated oncology and infusion center, bringing breast cancer prevention, infusion therapy, plastic surgery, rheumatology, medical oncology and survivorship services to one coordinated space. The $2 million renovation expanded the center’s…
Once viewed primarily as weight loss and diabetes drugs, GLP-1 medications are drawing increased scrutiny in oncology. Leaders are beginning to examine what the drugs could mean for cancer risk and outcomes, as a growing body of research suggests the…
Naples (Fla.) Comprehensive Health has received $10 million to support women’s cancer care services. The gift will fund services across multiple NCH facilities, including an outpatient infusion center and the women’s oncology surgical wing at NCH North Hospital, according to…
Adults younger than 65 now account for 45% of all newly diagnosed colorectal cancer cases in the U.S., up from 27% in 1995, according to the American Cancer Society’s “Colorectal Cancer Statistics, 2026” report published March 2 in CA: A…
Stanford (Calif.) Cancer Institute has tapped Vivek Subbiah, MD, as inaugural associate director for drug development and precision oncology. Dr. Subbiah was also appointed as executive medical director for cancer novel therapies and clinical trial network development at Stanford (Calif.)…
For decades, oncology programs have measured success by volume, speed and five-year survival rates. Ten cancer leaders told Becker’s these benchmarks are increasingly disconnected from what matters most: timely, equitable access to evidence-based treatment and outcomes that reflect both survival…
Co-located multidisciplinary clinics — where newly diagnosed cancer patients meet with all of their cancer specialists on the same day — can expedite time to treatment, reduce costs and improve outcomes, according to a study published Feb. 20 in the…
A team at Philadelphia-based Fox Chase Cancer Center has developed a patient education program aimed at improving clinical trial enrollment. The multidisciplinary team created the program after interviewing and collaborating with kidney cancer patients, according to a Feb. 26 news…
Houston Methodist has tapped Daniela Matei, MD, as director of the Dr. Mary and Ron Neal Cancer Center. Dr. Matei will step into the role in April, according to a Feb. 27 news release from Houston Methodist. She currently serves…
BeOne Corporate Video
BeOne Medicines is a global oncology company discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of novel therapeutics through its internal capabilities and…
